Range
5.95 - 6.11
Vol / Avg.
6.3K/39K
Div / Yield
-
52 Wk
5.91 - 18.95
Mkt Cap
242.9M
Payout Ratio
-
Open
5.95
P/E
-
Shares
40.6M
Outstanding
40.6M
Total Float
-
Benzinga - 1 day ago
Benzinga - Jul 1, 2021, 8:12AM
Benzinga - Jun 4, 2021, 9:11AM
Benzinga - May 11, 2021, 7:25AM
Benzinga - May 5, 2021, 8:46AM
Benzinga - Apr 26, 2021, 8:59AM
Benzinga - Apr 26, 2021, 8:00AM
Benzinga - Apr 26, 2021, 7:51AM
Benzinga - Apr 26, 2021, 7:24AM
Benzinga - Apr 26, 2021, 6:15AM
Benzinga - Apr 26, 2021, 6:11AM
Benzinga - Apr 12, 2021, 10:19AM
load more
Sector: Health Care.Industry: Biotechnology
Achilles Therapeutics PLC is a biopharmaceutical company. It is developing novel cancer immunotherapies targeting clonal neoantigens. The company has two ongoing trials, the CHIRON trial in patients with advanced non-small cell lung cancer and the THETIS trial in patients with recurrent or metastatic melanoma.

Earnings

see more
Q2 2021Est.ActualSurprise
EPS
(EXPECTED)2021-08-10
REV
Q1 2021Est.ActualSurprise
EPS-8.380
REV0

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target

Related Companies

TickerCompanyChg %Mkt Cap
ACHLAchilles Therapeutics10.7%242.9M

Achilles Therapeutics Frequently Asked Questions

Q

How do I buy Achilles Therapeutics (ACHL) stock?

A

You can purchase shares of Achilles Therapeutics (NASDAQ: ACHL) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are Achilles Therapeutics's (ACHL) competitors?

A

Other companies in Achilles Therapeutics’s space includes: Vincerx Pharma (NASDAQ:VINC), Innate Pharma (NASDAQ:IPHA), Kezar Life Sciences (NASDAQ:KZR), HOOKIPA Pharma (NASDAQ:HOOK) and Jounce Therapeutics (NASDAQ:JNCE).

Q

What is the target price for Achilles Therapeutics (ACHL) stock?

A

The latest price target for Achilles Therapeutics (NASDAQ: ACHL) was reported by JP Morgan on April 26, 2021. The analyst firm set a price target for 11.00 expecting ACHL to rise to within 12 months (a possible 83.95% upside). 5 analyst firms have reported ratings in the last year.

Q

Current Stock Price for Achilles Therapeutics (ACHL)?

A

The stock price for Achilles Therapeutics (NASDAQ: ACHL) is $5.98 last updated Today at 8:00:01 PM.

Q

Does Achilles Therapeutics (ACHL) pay a dividend?

A

There are no upcoming dividends for Achilles Therapeutics.

Q

When is Achilles Therapeutics (NASDAQ:ACHL) reporting earnings?

A
Achilles Therapeutics’s Q3 earnings are confirmed for after-market on October 27, 2021.
Q

Is Achilles Therapeutics (ACHL) going to split?

A

There is no upcoming split for Achilles Therapeutics.

Q

What sector and industry does Achilles Therapeutics (ACHL) operate in?

A

Achilles Therapeutics is in the Consumer Discretionary sector and Multiline Retail industry. They are listed on the NASDAQ.